The association between ethnic background and characteristics of first mental health treatment for psychotic disorders in the Netherlands between 2001 and 2005
Fassaert, T., Heijnen, H., de Wit, M.A.S.,
Peen, J.,
Beekman, A.T.F. &
Dekker, J.J.M.Verschenen in Social Psychiatry and Psychiatric Epidemiology, 51, 1591–1601 (2016)
Glutamatergic markers, age, intellectual functioning and psychosis in 22q11 deletion syndrome.
Evers, L.J., van Amelsvoort, T.A., Bakker, J.A.,
De Koning, M.B., Drukker, M. & Curfs, L.M.
Verschenen in Psychopharmacology (Berl), 232 (18), 3319-3325 (2015)
PRODH rs450046 and proline x COMT Val¹⁵⁸ Met interaction effects on intelligence and startle in adults with 22q11 deletion syndrome
De Koning, M.B., van Duin, E.D., Boot, E., Bloemen, O.J., Bakker, J.A., Abel, K.M. & van Amelsvoort, T.A.
Verschenen in Psychopharmacology (Berl), 232, 3111-3122 (2015)
Victimisation in adults with severe mental illness: prevalence and risk factors
De Mooij, L.D.,
Kikkert, M.J.,
Lommerse, N.M.,
Peen, J., Meijwaard, S.C., Theunissen, J.,
Duurkoop, P.W.R.A.,
Goudriaan, A.E.,
Van, H.,
Beekman, A.T.F. &
Dekker, J.J.M.Verschenen in The British Journal of Psychiatry, 207, 515-522 (2015)
Pre-pulse inhibition and striatal dopamine in subjects at an ultra-high risk for psychosis
De Koning, M.B., Bloemen, O.J.N., van Duin, E.D.A., Booij, J., Abel, K.M.,
De Haan, L., Linszen, D.H. & van Amelsvoort, T.A.M.J.
Verschenen in Journal of Psychopharmacology, 28 (6), 553-560 (2014)
Psychometric properties of the Dutch version of the Self-Sufficiency Matrix (SSM-D)
Fassaert, T., Lauriks, S., van de Weerd, S., Theunissen, J.,
Kikkert, M.J.,
Dekker, J.J.M., Buster, M. & de Wit, M.
Verschenen in Community Mental Health, 50 (5), 583-590 (2013)
Are long-term psychiatric patients causing more crisis consultations outside office hours in mental health care?
Dekker, J.J.M., Theunissen, J.,
Van, H.,
Kikkert, M.J.,
Van der Post, L.,
Zoeteman, J. &
Peen, J.Verschenen in International Journal of Social Psychiatry, 59 (6) (2012)
Striatal dopamine D2/3 receptor binding following dopamine depletion in subjects at Ultra High Risk for psychosis
Bloemen, O.J.N.,
De Koning, M.B., Gleich, T., Meijer, J.,
De Haan, L., Linszen, D.H., Booij, J. & van Amelsvoort, T.A.M.J.
Verschenen in European Neuropsychopharmacology, 23 (2), 126-132 (2013)
Startle reactivity and prepulse inhibition of the acoustic startle response are modulated by catechol-O-methyl-transferase Val158Met polymorphism in adults with 22q11 deletion syndrome
De Koning, M.B., Boot, E., Bloemen, O.J.N., van Duin, E.D.A., Abel, K.M.,
De Haan, L., Linszen, D.H. & van Amelsvoort, T.A.M.J.
Verschenen in Journal of Psychopharmacology, 26 (12), 1548-1560 (2012)
Na de extramuralisering; een retrospectief onderzoek naar omvang en zorggebruik van de groep chronische patiënten in de Amsterdamse ggz
Peen, J., Theunissen, J.,
Duurkoop, P.W.R.A.,
Kikkert, M.J. &
Dekker, J.J.M.Verschenen in Tijdschrift voor Psychiatrie, 53 (8), 509-517 (2011)
Hippocampal Glutamate Levels and Striatal Dopamine D2/3 Receptor Occupancy in Subjects at Ultra High Risk of Psychosis
Bloemen, O.J.N., Gleich, T.,
De Koning, M.B., da Silva Alvis, F.,
De Haan, L., Linszen, D.H., Booij, J. & van Amelsvoort, T.A.M.J.
Verschenen in Biological Psychiatry, 70 (1), e1-e2 (2011)
The predective validity of subjective adherence measures in patients with schizophrenia
Kikkert, M.J., Koeter, M.W.J.,
Dekker, J.J.M., Burti, L., Robson, D., Puschner, B. & Schene, A.H.
Verschenen in International Journal of Mehods in Psychiatric Research, 20 (2), 73-81 (2011)
Victimization of patients with severe psychiatric disorders: prevalence, risk factors, protective factors and consequences for mental health. A longitudinal study
Dekker, J.J.M., Theunissen, J.,
Van, H.,
Peen, J.,
Duurkoop, P.W.R.A. &
Kikkert, M.J.Verschenen in BMC Public Health, 10, 687 (2011)
Effect of medication-related factors on adherence in people with schizophrenia: An European multi-centre study
Meier, J., Becker, T., Patel, A., Robson, D., Schene, A.H.,
Kikkert, M.J., Barbui, C., Burti, L. & Puschner, B.
Verschenen in Epidemiology and Psychiatric Sciences, 19 (3), 251-259 (2010)
Implicit and explicit affective associations towards cannabis use in patients with recent-onset schizophrenia and healthy controls
Dekker, N., Smeerdijk, A.M., Wiers, R.W., Duits, J.H., van Gelder, G., Houben, K., Schippers, G., Linszen, D.H. &
De Haan, L.Verschenen in Psychological Medicine, 40 (8), 1325-1336 (2010)
White-matter markers for psychosis in a prospective ultra-high-risk cohort
Bloemen, O.J.N.,
De Koning, M.B., Schmitz, N., Nieman, D.H., Becker, H.E.,
De Haan, L., Dingemans, P., Linszen, D.H. & van Amelsvoort, T.A.M.J.
Verschenen in Psychological Medicine, 40 (8), 1297-1304 (2010)
Crisis intervention and acute pscyhiatry in Amsterdam, 20 years of change: A historical comparison of consultations in 1983 and 2004-2005
Van der Post, L.,
Dekker, J.J.M., Jonkers, J.F.J.,
Beekman, A.T.F., Mulder, C.L.,
De Haan, L., Mulder, W.G. & Schoevers, R.A.
Verschenen in International Journal of Social Psychiatry, 56 (4), 348-359 (2010)
Early intervention in patients at ultra high risk of psychosis: benefits and risks.
De Koning, M.B., Bloemen, O.J.N., van Amelsvoort, T.A.M.J., Becker, H.E., Nieman, D.H., van der Gaag, M. & Linszen, D.H.
Verschenen in Acta Psychiatrica Scandinavia, 119 (6), 426-442 (2009)
Challenge and therapeutic studies using alpha-methyl-para-tyrosine (AMPT) in neuropsychiatric disorders: a review
Bloemen, O.J.N.,
De Koning, M.B., Boot, E., Booij, J. & van Amelsvoort, T.A.M.J.
Verschenen in Central Nervous System Agents in Medicinal Chemistry, 8 (4), 249-256 (2008)
